Article
Expression profiling of CD34 <sup>+</sup> hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia
4 Nov 2002
Abstract excerpt
One of the most serious consequences of cytotoxic cancer therapy is the development of therapy-related acute myeloid leukemia (t-AML), a neoplastic disorder arising from a multipotential hematopoietic stem cell. To gain insights into the molecular basis of this disease, we performed gene expression profiling of CD34(+) hematopoietic progenitor cells from t-AML patients. Our analysis revealed that there are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
